Evidence map›Paper›PMID 32701209›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action.

Christine M Durand, Wanying Zhang, Diane M Brown, Sile Yu, Niraj Desai, Andrew D Redd, Serena M Bagnasco, Fizza F Naqvi, Shanti Seaman, Brianna L Doby and 28 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  4. Article
  5. Potential pool of cardiothoracic organs from donors with HIV.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Updates on Donor-Derived Infection in Solid Organ Transplantation, Report from the 2024 GTI (Infection and Transplantation Group) Annual Meeting.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  16. Observational
  17. Perspective on donor-derived infections in Italy.Transplant infectious disease : an official journal of the Transplantation Society · 2024
    Review
  18. Safety of Kidney Transplantation from Donors with HIV.The New England journal of medicine · 2024
    Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors at 15 institutions in 2 countries.

Christine M DurandDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-2605-9257
Wanying ZhangDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Diane M BrownDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sile YuDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-9956-2526
Niraj DesaiDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Andrew D ReddDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Serena M BagnascoDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Fizza F NaqviDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Shanti SeamanDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Brianna L DobyDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Darin OstranderDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mary Grace BowringDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-7299-7730
Yolanda EbyDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Reinaldo E FernandezDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Rachel Friedman-MoracoDepartment of Medicine, Emory University, Atlanta, Georgia, USA.
Nicole TurgeonDepartment of Surgery, Emory University, Atlanta, Georgia, USA.
Peter StockDepartment of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0002-5806-0167
Peter Chin-HongDepartment of Medicine, University of California, San Francisco, California, USA.
Shikha MehtaSection of Transplant Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Valentina StosorDepartment of Infectious Diseases and Organ Transplantation, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Catherine B SmallDepartment of Medicine/Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0002-0601-6615
Gaurav GuptaDepartment of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0003-1919-1970
Sapna A MehtaNYU Langone Transplant Institute, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-5588-905X
Cameron R WolfeDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Jennifer HussonInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Alexander GilbertMedstar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, District of Columbia, USA.ORCID 0000-0001-5069-1880
Matthew CooperMedstar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, District of Columbia, USA.ORCID 0000-0002-3438-9638
Oluwafisayo AdebiyiDepartment of Medicine, Indiana University Health Hospital, Indianapolis, Indiana, USA.ORCID 0000-0002-3212-5831
Avinash AgarwalDepartment of Surgery, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Elmi MullerDepartment of Surgery, University of Cape Town, Cape Town, South Africa.
Thomas C QuinnDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jonah OdimDivision of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Shirish HuprikarRecanati-Miller Transplantation Institute, The Mount Sinai Hospital, New York, New York, USA.
Sander FlormanRecanati-Miller Transplantation Institute, The Mount Sinai Hospital, New York, New York, USA.
Allan B MassieDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-5288-5125
Aaron A R TobianDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Dorry L SegevDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-1924-4801
HOPE in Action Investigators
Johns Hopkins University · USNational Institutes of Health · USEmory University · USGeorgetown University · USMount Sinai Hospital · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USCornell University · USDuke Medical Center · USIndiana University Health · USNorthwestern University · USUniversity of Cape Town · ZAUniversity of Maryland, Baltimore · USUniversity of Virginia Medical Center · USVirginia Commonwealth University · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver TransplantationU01AI138897 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Christine Marie Durand, DORRY L. SEGEV · 2018 to 2026
$25.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantationU01AI134591 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DURAND, CHRISTINE MARIE, SEGEV, DORRY L. · 2017 to 2021
$11.0M
Unlocking the Potential of HIV-Infected Deceased Donors for Organ TransplantationR01AI120938 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2016 to 2021
$4.3M
Patient Oriented Research in Solid Organ TransplantationK24AI144954 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SEGEV, DORRY L. · 2020 to 2024
$956k
NCI NIH HHS P30 CA006973NIAID NIH HHS K24 AI144954NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI120938NIAID NIH HHS U01 AI134591NIAID NIH HHS U01 AI138897NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

HIV-positive donor to HIV-positive recipient (HIV D+/R+) transplantation is permitted in the United States under the HIV Organ Policy Equity Act. To explore safety and the risk attributable to an HIV+ donor, we performed a prospective multicenter pilot study comparing HIV D+/R+ vs HIV-negative donor to HIV+ recipient (HIV D-/R+) kidney transplantation (KT). From 3/2016 to 7/2019 at 14 centers, there were 75 HIV+ KTs: 25 D+ and 50 D- (22 recipients from D- with false positive HIV tests). Median follow-up was 1.7 years. There were no deaths nor differences in 1-year graft survival (91% D+ vs 92% D-, P = .9), 1-year mean estimated glomerular filtration rate (63 mL/min D+ vs 57 mL/min D-, P = .31), HIV breakthrough (4% D+ vs 6% D-, P > .99), infectious hospitalizations (28% vs 26%, P = .85), or opportunistic infections (16% vs 12%, P = .72). One-year rejection was higher for D+ recipients (50% vs 29%, HR: 1.83, 95% CI 0.84-3.95, P = .13) but did not reach statistical significance; rejection was lower with lymphocyte-depleting induction (21% vs 44%, HR: 0.33, 95% CI 0.21-0.87, P = .03). In this multicenter pilot study directly comparing HIV D+/R+ with HIV D-/R+ KT, overall transplant and HIV outcomes were excellent; a trend toward higher rejection with D+ raises concerns that merit further investigation.

Indexed as

HIV InfectionsKidney TransplantationFollow-Up StudiesGraft RejectionGraft SurvivalHumansPilot ProjectsProspective StudiesRisk FactorsTissue Donorsclinical research/practiceclinical trialdonors and donation: deceasedethics and public policyinfection and infectious agentsinfection and infectious agents - viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)infectious diseasekidney transplantation/nephrologylaw/legislationrejection

Identifiers

PMID32701209
PMCPMC8073960
OpenAlexW3043912618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.